Deltex Medical (LON:DEMG) - Nearing the end of the beginning?
Oct 09th 2012 - Edison Investment Research today published a report on Deltex Medical (DEMG.L, LSE:DEMG, LON:DEMG) entitled "Nearing The End Of The Beginning?". In summary, the report says:
Deltex has a commanding position in patient fluid management in major surgery. However, the NHS has slipped in its implementation plan, still not published, and watered down the threatened penalties on hospitals for not adopting fluid management. Despite this, UK surgical probe sales were up 28% by volume in H1 and accounted for 9% of Deltex’s 7% H1 growth; net other sales fell 2%. In the US, H1 probe volumes were down 3%, but clinical data from Duke (due late 2012) might start to generate growth in 2013; the US is critical to Deltex delivering its growth promise. European probe volumes were up 40%, but offset by a fall in monitor sales; RoW probe volumes fell but are heavily H2...
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »
